Traditional and Modern Biomedical Prospecting: Part I—the History
Nature, especially the marine environment, provides the most effective drugs used in human therapy. Among the metazoans, the marine sponges (phylum Porifera), which are sessile filter feeders, produce the most potent and highly selective bioactive secondary metabolites. These animals (or their assoc...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2004-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1093/ecam/neh013 |
id |
doaj-7a8f6cc0252c4949ba047dbdb4b0c780 |
---|---|
record_format |
Article |
spelling |
doaj-7a8f6cc0252c4949ba047dbdb4b0c7802020-11-24T23:25:46ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-427X1741-42882004-01-0111718210.1093/ecam/neh013Traditional and Modern Biomedical Prospecting: Part I—the HistoryWerner E. G. Müller0Renato Batel1Heinz C. Schröder2Isabel M. Müller3Institut für Physiologische Chemie, Abteilung Angewandte Molekularbiologie, Universität, Duesbergweg 6, D-55099 Mainz, GermanyCenter for Marine Research, Ruder Boskovic Institute, HR-52210 Rovinj, CroatiaInstitut für Physiologische Chemie, Abteilung Angewandte Molekularbiologie, Universität, Duesbergweg 6, D-55099 Mainz, GermanyInstitut für Physiologische Chemie, Abteilung Angewandte Molekularbiologie, Universität, Duesbergweg 6, D-55099 Mainz, GermanyNature, especially the marine environment, provides the most effective drugs used in human therapy. Among the metazoans, the marine sponges (phylum Porifera), which are sessile filter feeders, produce the most potent and highly selective bioactive secondary metabolites. These animals (or their associated symbiotic microorganisms) synthesize secondary metabolites whose activity and selectivity has developed during their long evolutionary history (evochemistry). The exploitation of these resources has become possible due to the progress in molecular and cell biology. BIOTECmarin, the German Center of Excellence follows this rationale. In the past, these animals have been successfully and extensively utilized to isolate bioactive compounds and biomaterials for human benefit. Pharmaceuticals prepared from marine animals, primarily sponges, have been applied since ancient times (Hippocrates, Aristotle and later Plinius). It has been reported that extracts and/or components from sponges can be used for the treatment of specific diseases. For a systematic and applied-oriented exploitation, the successful development of effective compounds largely depends on quality of the institutional infrastructure of marine stations and more so on the biodiversity. The Center for Marine Research in Rovinj (Croatia) fulfils these prerequisites. Founded in 1891, this institute has to its credit major discoveries related to exploitation of secondary metabolites/biomaterials from sponges for therapeutical application and to obtain biomaterials for general wellbeing.This is the first part of a review focusing on biomedical prospecting. Here, we have mainly described the historic background. The details of techniques, substances, approaches and outlooks will be discussed in the second part.http://dx.doi.org/10.1093/ecam/neh013 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Werner E. G. Müller Renato Batel Heinz C. Schröder Isabel M. Müller |
spellingShingle |
Werner E. G. Müller Renato Batel Heinz C. Schröder Isabel M. Müller Traditional and Modern Biomedical Prospecting: Part I—the History Evidence-Based Complementary and Alternative Medicine |
author_facet |
Werner E. G. Müller Renato Batel Heinz C. Schröder Isabel M. Müller |
author_sort |
Werner E. G. Müller |
title |
Traditional and Modern Biomedical Prospecting: Part I—the History |
title_short |
Traditional and Modern Biomedical Prospecting: Part I—the History |
title_full |
Traditional and Modern Biomedical Prospecting: Part I—the History |
title_fullStr |
Traditional and Modern Biomedical Prospecting: Part I—the History |
title_full_unstemmed |
Traditional and Modern Biomedical Prospecting: Part I—the History |
title_sort |
traditional and modern biomedical prospecting: part i—the history |
publisher |
Hindawi Limited |
series |
Evidence-Based Complementary and Alternative Medicine |
issn |
1741-427X 1741-4288 |
publishDate |
2004-01-01 |
description |
Nature, especially the marine environment, provides the most effective drugs used in human therapy. Among the metazoans, the marine sponges (phylum Porifera), which are sessile filter feeders, produce the most potent and highly selective bioactive secondary metabolites. These animals (or their associated symbiotic microorganisms) synthesize secondary metabolites whose activity and selectivity has developed during their long evolutionary history (evochemistry). The exploitation of these resources has become possible due to the progress in molecular and cell biology. BIOTECmarin, the German Center of Excellence follows this rationale. In the past, these animals have been successfully and extensively utilized to isolate bioactive compounds and biomaterials for human benefit. Pharmaceuticals prepared from marine animals, primarily sponges, have been applied since ancient times (Hippocrates, Aristotle and later Plinius). It has been reported that extracts and/or components from sponges can be used for the treatment of specific diseases. For a systematic and applied-oriented exploitation, the successful development of effective compounds largely depends on quality of the institutional infrastructure of marine stations and more so on the biodiversity. The Center for Marine Research in Rovinj (Croatia) fulfils these prerequisites. Founded in 1891, this institute has to its credit major discoveries related to exploitation of secondary metabolites/biomaterials from sponges for therapeutical application and to obtain biomaterials for general wellbeing.This is the first part of a review focusing on biomedical prospecting. Here, we have mainly described the historic background. The details of techniques, substances, approaches and outlooks will be discussed in the second part. |
url |
http://dx.doi.org/10.1093/ecam/neh013 |
work_keys_str_mv |
AT werneregmuller traditionalandmodernbiomedicalprospectingpartithehistory AT renatobatel traditionalandmodernbiomedicalprospectingpartithehistory AT heinzcschroder traditionalandmodernbiomedicalprospectingpartithehistory AT isabelmmuller traditionalandmodernbiomedicalprospectingpartithehistory |
_version_ |
1725556130626666496 |